Pf In Conversation: David Martin on working with pharma to benefit of MS patients

Pf Head of Content, Emma Morriss interviews David Martin, Chief Executive of the MS Trust for Pf in Conversation. They discuss steps being taken to find treatments and research, the need to find treatments to reverse the progression of symptoms and the need for the pharmaceutical industry to engage, collaborate with and support the multiple sclerosis community.

For more on multiple sclerosis, and understanding the condition.